Regenerative Medicine Media for Cell and Gene Therapy Applications

Regenerative Medicine Media for Cell and Gene Therapy Applications

Regenerative Medicine Media for Cell and Gene Therapy Applications

Regenerative Medicine Media for Cell and Gene Therapy Applications

Robust Efficient Performance for Cell and Gene Therapy Applications

In regenerative medicine and cell therapy treatments cells are treated as the medical product replacing missing or dysfunctional patient´s cells. Cells are taken from the donor, cultivated, expanded and eventually manipulated ex-vivo before being administrated to the patient. The cells can either be autologous (where the recipient is also the donor) or allogeneic (where the donor and recipient are distinct individuals). The cells used in cell therapy can be primary cells or from cell lines. The most important cells are hematopoietic cells (T or B lymphocytes, dendritic or natural killer cells), tissue cells (skin, etc.), and stem cells isolated from bone marrow and fat tissues.

Media for Gene and Cell Therapy Processes

Customized Solutions for Unique Needs

Production-Focused Approach to Produce Your Unique Media Solutions

Perfect choice for clients who have known, desired media composition and outcome expectations. For critical raw materials you can either request specific suppliers or rely upon Sartorius’s established global network of qualified suppliers. Customized packaging, media formats, and release assays are also available upon request.

Attractive Other Media for Primary Cell-Based Processes

 

By sending an enquiry to Sartorius you confirm that you have read the Declaration of Consent (found in downloadable content) regarding the data processing for marketing purposes by Sartorius and consent to this processing.

 

 

 

 

 

 

 

Read more...

To contact Sartorius Australia Pty Ltd about Regenerative Medicine Media for Cell and Gene Therapy Applications use Get A Quote.

Robust Efficient Performance for Cell and Gene Therapy Applications

In regenerative medicine and cell therapy treatments cells are treated as the medical product replacing missing or dysfunctional patient´s cells. Cells are taken from the donor, cultivated, expanded and eventually manipulated ex-vivo before being administrated to the patient. The cells can either be autologous (where the recipient is also the donor) or allogeneic (where the donor and recipient are distinct individuals). The cells used in cell therapy can be primary cells or from cell lines. The most important cells are hematopoietic cells (T or B lymphocytes, dendritic or natural killer cells), tissue cells (skin, etc.), and stem cells isolated from bone marrow and fat tissues.

Media for Gene and Cell Therapy Processes

Customized Solutions for Unique Needs

Production-Focused Approach to Produce Your Unique Media Solutions

Perfect choice for clients who have known, desired media composition and outcome expectations. For critical raw materials you can either request specific suppliers or rely upon Sartorius’s established global network of qualified suppliers. Customized packaging, media formats, and release assays are also available upon request.

Attractive Other Media for Primary Cell-Based Processes

 

By sending an enquiry to Sartorius you confirm that you have read the Declaration of Consent (found in downloadable content) regarding the data processing for marketing purposes by Sartorius and consent to this processing.

 

 

 

 

 

 

 

Read less...

To contact Sartorius Australia Pty Ltd about Regenerative Medicine Media for Cell and Gene Therapy Applications use Get A Quote.

Declaration_of_Consent2 (48)(0.26MB)